WuXi Biology Launches PeptideDEL 2.0

Expanded Diversity, Enhanced Screening Power:

WuXi Biology is pleased to introduce PeptideDEL 2.0, our upgraded DNA-encoded peptide library designed to advance drug discovery by enabling high-throughput exploration of vast chemical space with 350+ billion unique peptide compounds, expanding opportunities for peptide-based drug discovery.

This enhanced library features a broader peptide size range of 4-12 amino acids, incorporation of 1,200+ unnatural amino acids, and 6 advanced cyclization strategies, enabling expansive coverage of peptide chemical space.

Backed by our extensive screening experience—50+ targets screened across more than 10 target classes and diverse therapeutic areas—our platform delivers >70% screening success rate, providing reliable performance for diverse screening needs, including challenging targets.

For a limited time, we’re offering a 10% introductory discount valid until April 30, 2026. Learn how PeptideDEL 2.0 can accelerate your discovery programs!